Quantcast

Latest Autoimmunity Stories

2014-01-14 16:25:08

Brings Total to $6.6 Million to Educate Healthcare Professionals on Front-Lines of Care NEW YORK, Jan. 14, 2014 /PRNewswire/ -- The 2014 Omnibus Appropriations Bill released by the U.S. Congress last night provides $2 million to further the Lupus Initiative, the lupus provider education program conceived by the Lupus Research Institute (LRI) in collaboration with the federal government. Expected to pass this week, the appropriation will bring total support to $6.6 million for the...

2014-01-13 12:27:53

SEATTLE, Jan. 13, 2014 /PRNewswire/ -- Adaptive Biotechnologies announced today a biomarker discovery agreement facilitated by the Johnson & Johnson Innovation Center in California. Under the agreement, Adaptive will use its patented immune profiling assay, immunoSEQ(TM), to enable an in-depth characterization of the immune response to diseases being studied and select immunology and oncology drugs being developed by Janssen Research & Development, LLC (Janssen). The...

2014-01-08 08:28:48

PORTLAND, Ore., Jan. 8, 2014 /PRNewswire-USNewswire/ -- To advance understanding of psoriasis--the most common autoimmune disease in the country, affecting up to 7.5 million Americans--and help scientists and clinicians improve treatments and patient outcomes, the National Psoriasis Foundation (NPF) and the Consortium of Rheumatology Researchers of North America, Inc. (CORRONA) will create the first psoriasis registry co-developed and co-administered by a nonprofit. (Photo:...

2014-01-07 23:01:17

A 2.5-Day Summit Providing Groundbreaking Approaches to Treating Patients With Interrelated Autoimmune Conditions Malvern, PA (PRWEB) January 07, 2014 The Interdisciplinary Autoimmune Summit (IAS) is pleased to announce the Keynote Address to be presented by Noel R. Rose, MD, PhD, Professor of Pathology, Professor of Molecular Microbiology and Immunology, Director, Johns Hopkins Center for Autoimmune Disease Research, The Johns Hopkins Medical Institutions. On Friday, June 20, 2014 at...

2014-01-06 08:25:03

EDGEWATER, N.J., Jan. 6, 2014 /PRNewswire/ -- DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy. DV-0100 is proprietary, novel and safe. The therapy halt's the body's autoimmune reaction against the pancreatic islet cells which are responsible for producing insulin, thus allowing them to produce insulin normally and...

2013-12-31 16:22:09

What is Lupus? WASHINGTON, Dec. 31, 2013 /PRNewswire-USNewswire/ -- There have been many reports and rumors in the media and on the internet, asking questions about the autoimmune disease lupus and who might be suffering from this devastating disease. (Photo: http://photos.prnewswire.com/prnh/20131231/DC39345-INFO) (Logo: http://photos.prnewswire.com/prnh/20121113/DC11393LOGO) The real question is: what is lupus? What are the debilitating effects of living with the disease? When...

2013-12-19 10:35:03

A newly identified immune protein influences each person's response to vaccines and risk for autoimmune diseases like lupus and multiple sclerosis, according to a study published today by researchers from the School of Medicine at the University of Alabama at Birmingham in the journal Science Translational Medicine. The protein, called a receptor and part of signaling pathways, also provides a new target for personalized therapies for patients with autoimmune diseases. The research team...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related